相关实验视频

Updated: Jul 28, 2026

Metabolic Characterization of Polarized M1 and M2 Bone Marrow-derived Macrophages Using Real-time Extracellular Flux Analysis

Metabolic Characterization of Polarized M1 and M2 Bone Marrow-derived Macrophages Using Real-time Extracellular Flux Analysis

Published on: November 28, 2015

工程M2型巨细胞具有金属聚网络,用于治疗外围动脉疾病

Jianwei Duan¹, Zuoguan Chen², Xiaoyu Liang³

¹Tianjin Key Laboratory of Biomaterial Research, Institute of Biomedical Engineering, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin, 300192, PR China.

Free radical biology & medicine

|January 13, 2024

概括

金属多网络在关键四肢缺血 (CLI) 中保护M2巨细胞. 这种增强的细胞存活率可以改善血液流动和肌肉再生,为CLI提供一种新的基于细胞的治疗方法.

科学领域:

生物材料科学生物材料科学
再生医学是一种再生医学.
血管生物学血管生物学

背景情况:

关键四肢缺血症 (CLI) 治疗受到恶劣缺血环境中细胞存活率低下的挑战.
M2巨细胞促进组织修复,但由于新陈代谢快速,它们在体内有效性有限.
金属聚网络为保护移植细胞提供了一个有希望的策略.

研究的目的:

开发一种使用金属多网络的新型细胞输送系统,以提高M2巨的存活率和CLI的治疗潜力.
研究网络内的铜离子和表甲基酸盐 (Cu-EGCG) 对M2巨细胞的协同作用.
在后肢缺血的小鼠模型中评估Cu-EGCG装饰的M2巨细胞 (Cu-EGCG@M2) 的疗效.

主要方法:

M2巨细胞被一个铜-甲基甲基酸金属-多网络 (Cu-EGCG@M2) 装饰.
进行了体外细胞活力测试,以评估在缺血条件下的细胞存活率.
在体内研究中,利用后肢缺血的小鼠模型来评估对血液流动,肌肉再生和四肢挽救的治疗效果.

主要成果:

在体外,Cu-EGCG@M2显著增加了M2巨细胞的活力.
装饰的巨细胞在体内表现出增强的生存率和延长的治疗时间.
Cu-EGCG@M2治疗促进了显著的血管生成,改善了血液输液,并促进了缺血后肢的肌肉再生,从而挽救了上肢.
治疗还改善了缺血性微环境,表现出抗氧化,抗炎和益血管性质.

结论:

金属多网络封装有效地保护M2巨细胞,增强其治疗治疗关节缺血的疗效.
Cu-EGCG@M2代表了一种可行的基于细胞的治疗策略,用于促进缺血病的血管生成和组织修复.
这种方法为改善关键肢体缺血患者的治疗结果提供了一个有希望的新途径.

关键词:

血管新生的产生.缺血缺血是因为缺血.M2类型的巨细胞.金属多网络的金属多网络.

更多相关视频

A Multi-Cue Bioreactor to Evaluate the Inflammatory and Regenerative Capacity of Biomaterials under Flow and Stretch

A Multi-Cue Bioreactor to Evaluate the Inflammatory and Regenerative Capacity of Biomaterials under Flow and Stretch

Published on: December 10, 2020

Polarization and Characterization of M1 and M2 Human Monocyte-Derived Macrophages on Implant Surfaces

Polarization and Characterization of M1 and M2 Human Monocyte-Derived Macrophages on Implant Surfaces

Published on: December 6, 2024

相关概念视频

Peripheral Artery Disease I: Introduction

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...